← back to search

Jin‐hong Park

Ulsan College · KR
Area of research
Oncology · Hepatology · test6
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Colorectal Cancer Surgical Treatments, and Advanced Radiotherapy Techniques.
h-index
40
citations
6,631
works
355
NIH funding
primary concept
Medicine
email

Recent publications

Therapeutic efficacy of nimodipine and topiramate on migraine and vestibular migraine; A prospective multicenter open-label study.
PloS one 2026cited by 0position: contributordoi
Quantifying Interfractional Motion in Patients With Anorectal Cancer During Radiotherapy and Recommendations of Optimal Planning Target Volume Margins.
2025cited by 0position: contributordoi
Local control and toxicity outcomes following consolidative radiation therapy in patients with high-risk neuroblastoma: a 20-year experience at a single center.
2024cited by 1position: contributordoi
A novel SLC26A9 inhibitor, S9-A13, reveals a minor contribution of SLC26A9 to constitutive airway chloride secretion
2024cited by 0position: middledoi
Adjuvant gemcitabine plus cisplatin versus capecitabine in node-positive extrahepatic cholangiocarcinoma: the STAMP randomized trial
Hepatology 2023cited by 52position: contributordoi
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study.
2022cited by 11position: contributordoi
Stereotactic Body Radiation Therapy versus Concurrent Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Propensity Score-Matched Analysis.
2022cited by 5position: contributordoi
Stereotactic body radiation therapy for pancreatic cancer: a potential ally in the era of immunotherapy?
2022cited by 2position: contributordoi
Radiation therapy for recurrent extrahepatic bile duct cancer.
2021cited by 3position: contributordoi
Stereotactic body radiation therapy for locally advanced pancreatic cancer.
2019cited by 41position: contributordoi
Fractionation of a Herbal Antidiarrheal Medicine Reveals Eugenol as an Inhibitor of Ca2+-Activated Cl− Channel TMEM16A
PLoS ONE 2012cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2019–2025)Sang Min Yoon · Kookmin University4 papers (2019–2022)Jong Hoon Kim · Seoul National University2 papers (2021–2022) · 2 papers (2022–2023)Jeong Yun Jang · Asan Medical Center2 papers (2022–2024)W. Namkung · Yonsei University2 papers (2012–2024)Changhoon Yoo · Eastern Hepatobiliary Surgery Hospital2 papers (2022–2023)Zhen Yao · South China Agricultural University1 papers (2012–2012) · 1 papers (2023–2023) · 1 papers (2023–2023) · 1 papers (2023–2023)Ho Joon Im · Asan Medical Center1 papers (2024–2024)Seonok Kim · Ulsan College1 papers (2022–2022)Do Hyun Park · Elsevier, Inc.1 papers (2022–2022)Myung Ah Lee · University of Ulsan1 papers (2023–2023) · 1 papers (2022–2022)Sung Han Kang · Asan Medical Center Children's Hospital1 papers (2024–2024)Dae Wook Hwang · Eastern Hepatobiliary Surgery Hospital1 papers (2023–2023)Kang Mo Kim · Asan Medical Center1 papers (2022–2022) · 1 papers (2023–2023)